Skip to content

Evaluation of Intra Axial Brain Masses Based on Magnetic Resonance in Adults

Impact of Advanced Neuroimaging Techniques in Evaluation of Intra Axial Brain Masses Based on Magnetic Resonance Diagnostic Strategy in Adults

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03166592
Enrollment
150
Registered
2017-05-25
Start date
2017-07-01
Completion date
2019-09-30
Last updated
2017-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor

Brief summary

Although the Magnetic resonance imaging with contrast is the gold standard for diagnosis of intra axial brain masses. The conventional Magnetic resonance imaging appearances of intra axial brain masses can be non-specific and even the use of contrast agent is of limited benefit. Contrast enhancement reflects only disruption of blood brain barrier. One third of high-grade malignancies are non-enhanced and may non-neoplastic lesions show contrast enhancement. Reliable differentiation of neoplastic from non-neoplastic brain masses, or of high grade from low grade tumor, is difficult with conventional Magnetic resonance imaging

Interventions

injection of gadolinium contrast then acquisition of images with magnetic resonance imaging then spectroscopy

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years

Inclusion criteria

1. Inclusion criteria: \* An intra axial space occupying lesion/lesions detected on conventional structural imaging 2.

Exclusion criteria

* MRI contraindications (as pace maker or claustrophobia). * Contrast hypersensitivity * Impaired renal function. * Pediatric age group

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with malignant masses1 hoursensitivity of the magnetic resonance spectroscopy in diagnosis of brain malignant masses

Countries

Egypt

Contacts

Primary ContactAhmed Abbas, MD
bmr90@hotmail.com00201003385183

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026